- Vouliez-vous dire
- risk
Résultats de la recherche - 7 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
protection, infections occurring before 2021 remained associated with significant risk reduction against symptomatic infection. Vaccination and prior infection outperformed vaccination or prior infection ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
on the risk of COVID-19 hospitalisation. We analysed aggregated data from 27,608 COVID-19 patients hospitalised between October 2021 and February 2022, stratified by age category and vaccination ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
a re-assessment. METHODS: We estimated VE against transmission of infection (VET) from Belgian contact tracing data for high-risk exposure contacts between 26/0½021 and 14/12/2021 by susceptibility (VE s) and ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
Wyndham-Thomas; Lucy Catteau Source: Viruses, Volume 14, Issue 4 (2022) Keywords: Ad26COVS1 Adult Belgium BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans incidence Prospective Studies Risk Factors SARS-CoV-2 ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
Goriely; Maria Goossens; Ariën, Kevin K; I Desombere; Arnaud Marchant Source: Clin Infect Dis (2021) Abstract: BACKGROUND: Residents of nursing homes (NH) are at high risk of COVID-19 related morbidity and ...
Identification of flavouring substances of genotoxic concern present in e-cigarette refills
compounds in e-liquids, flavourings of genotoxic concern are present and might pose a health risk for e-cigarette users. Health Topics: Effectiveness and safety of vaccines, medicines and health products- ...
General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
p.385-94 (2013) Keywords: Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Vaccination Viruses Abstract: This ...